Clinical Trial: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hodgkin Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Proof-of-Concept Multicenter Trial Evaluating Response Adapted Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
Brief Summary:
The goal of this clinical trial is to study the combination of nivolumab and axatilimab in patients with relapsed/refractory classical Hodgkin Lymphoma.This study will mainly look at if the combination works as expected.
Read more